TGINSIGHT SIMILAR POSTS
Изворен канал @pythonotes · Post #402 · 22 дек.
Отдельно разберём TaskGroup, который пришел на замену gather в Python 3.11. Ключевые отличия ▫️create_task() возвращает объект asyncio.Task, у которого есть соответствюущие методы управления. То есть у нас больше контроля ▫️это контекстный менеджер, который гарантирует что все таски будут остановлены по выходу из контекста ▫️ошибка автоматически отменяет незавершенные задачи, ▫️except* передает нам ExceptionGroup, в котором каждую ошибку можно обработать отдельно import asyncio import random async def do_it() -> str: if random.random() < 0.1: raise ValueError('Oops') delay = random.uniform(0.5, 1.5) await asyncio.sleep(delay) return delay async def main(): try: async with asyncio.TaskGroup() as tg: for _ in range(10): tasks.append(tg.create_task(do_it())) for t in tasks: print(t.result()) except *ValueError as e: for err in e.exceptions: print(err) asyncio.run(main()) Рекомендую изучить страницу Coroutines and Tasks из документации, где представлено больше интересных примеров и механизмов - таймауты - отмена задач - создание задач из другого потока #async
Hashtags
Пребарај: #biotechnology
@venturevillagewall · Post #3500 · 19.12.2024 г., 13:59
Xcell Biosciences Secures $1.4M Xcell Biosciences has raised $1.40 million for advancing its cell therapy manufacturing. The funding round took place on December 17, 2024. Learn more at Xcell Biosciences #XcellBiosciences#Funding#CellTherapy#SanFrancisco#Biotechnology#HealthTech
@venturevillagewall · Post #3574 · 20.12.2024 г., 09:33
Tessera Therapeutics Secures $50M Tessera Therapeutics has raised $50 million in funding on December 18, 2024. The early-stage life sciences company is at the forefront of Gene Writing™, a cutting-edge biotechnology aimed at transforming medicine and scientific research. More details available on their official website: Tessera Therapeutics #TesseraTherapeutics#Funding#LifeSciences#Biotechnology#GeneWriting#Healthcare#MedicalResearch
@venturevillagewall · Post #3627 · 21.12.2024 г., 10:22
First Oral Diabetes Therapy Funded TIXiMED has raised $2.65 million to develop TXNIP inhibiting medication, targeting Type 1 and Type 2 Diabetes with an innovative oral therapeutic. Learn more about their project here. #TIXiMED#Diabetes#Funding#Healthcare#TXNIP#Therapeutics#Type1Diabetes#Type2Diabetes#Biotechnology
@venturevillagewall · Post #3582 · 20.12.2024 г., 09:34
$140M Funding for Ottimo Pharma Ottimo Pharma announces a funding round of $140 million set for December 19, 2024. The company focuses on developing bi-functional medicines aimed at improving the lives of individuals living with cancer. Learn more #Funding#OttimoPharma#Cancer#BiFunctionalMedicines#Healthcare#Pharmaceuticals#LifeSciences#Investments#MedicalResearch#Oncology#HealthTech#Biotechnology
@venturevillagewall · Post #3557 · 20.12.2024 г., 09:32
Spine BioPharma Raises $13.51M Spine BioPharma has successfully closed a funding round totaling $13.51 million, announced on December 18, 2024. For more details, visit their official site: Spine BioPharma. #SpineBioPharma#Funding#BioPharma#Investment#Healthcare#LifeSciences#VentureCapital#Startup#ClinicalTrials#MedicinalResearch#Pharma#Innovations#Tech#Biotechnology#Market#Earnings#Growth#Investors#Equity
@venturevillagewall · Post #3629 · 21.12.2024 г., 10:22
$4.07M Funding for PeptiSystems PeptiSystems secured $4.07M in funding on December 20, 2024. The company develops advanced instruments for solid-phase synthesis in peptide and oligonucleotide therapeutics, catering to both GMP and non-GMP manufacturing. Discover more: PeptiSystems #Funding#PeptiSystems#Therapeutics#Peptides#Oligonucleotides#GMP#Manufacturing#Synthesis#Biotechnology#Pharmaceuticals#MedicalDevices#FlowthroughColumnTechnology#ProcessDevelopment#LifeSciences